Last Updated: May 3, 2026

Details for New Drug Application (NDA): 020886

✉ Email this page to a colleague

NDA 020886 describes PANRETIN, which is a drug marketed by Advanz Pharma and is included in one NDA. It is available from one supplier. Additional details are available on the PANRETIN profile page.

The generic ingredient in PANRETIN is alitretinoin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the alitretinoin profile page.

Summary for 020886

Tradename:	PANRETIN
Applicant:	Advanz Pharma
Ingredient:	alitretinoin
Patents:	0

Pharmacology for NDA: 020886

Suppliers and Packaging for NDA: 020886

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
PANRETIN	alitretinoin	GEL;TOPICAL	020886	NDA	Advanz Pharma (US) Corp.	59212-601	59212-601-22	60 g in 1 TUBE (59212-601-22)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	GEL;TOPICAL			Strength	EQ 0.1% BASE
Approval Date:	Feb 2, 1999	TE:		RLD:	Yes

Expired US Patents for NDA 020886

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Advanz Pharma	PANRETIN	alitretinoin	GEL;TOPICAL	020886-001	Feb 2, 1999	⤷ Start Trial	⤷ Start Trial
Advanz Pharma	PANRETIN	alitretinoin	GEL;TOPICAL	020886-001	Feb 2, 1999	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.